Middlesex, United Kingdom

José W Saldanha

This inventor holds 10 USPTO granted patents and 2 published patent applications and 2 EPO patents. Top assignees: Cytel Corporation, Millennium Pharmaceuticals Limited, Sloan-Kettering Institute for Cancer Research. Active years: 1998-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: José W Saldanha. Retrieved from https://idiyas.com/inventor/jose-w-saldanha

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 

% Patents Active = 80.0


Average Co-Inventor Count = 4.1

ph-index = 5

Forward Citations = 126(Granted Patents)


Location History:

  • Middlesex, GB (1998 - 2015)
  • Enfield, GB (2006 - 2017)

Company Filing History:


Years Active: 1998-2017

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovations of José W Saldanha

Introduction

José W Saldanha is a prominent inventor based in Middlesex, Great Britain. He has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. With a total of eight patents to his name, Saldanha's work has the potential to impact various medical treatments.

Latest Patents

Among his latest patents is the invention of humanized antibodies that recognize alpha-synuclein. This application discloses humanized 9E4 antibodies that bind to human alpha-synuclein and can be utilized for immunotherapy in treating Lewy body disease. Another notable patent involves anti-ganglioside GD3 antibodies and their uses. This invention relates to complementarity determining region (CDR)-grafted humanized R24 antibodies that bind to the GD3 ganglioside antigen. The humanized antibodies disclosed in this patent exhibit characteristics that are comparable or superior to the murine R24 antibody, making them useful in treating cancers such as melanoma.

Career Highlights

Saldanha has worked with several esteemed organizations throughout his career. Notably, he has been associated with Millennium Pharmaceuticals Limited and the Sloan-Kettering Institute for Cancer Research. His work in these institutions has allowed him to advance his research and contribute to significant medical innovations.

Collaborations

Some of his notable coworkers include Paul D Ponath and Douglas J Ringler. Their collaborative efforts have further enhanced the research and development of innovative solutions in the field of biotechnology.

Conclusion

José W Saldanha's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His work continues to pave the way for advancements in medical treatments and therapies.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…